Adventrx Finds Success In Vinorelbine Emulsion Study After CoFactor Failure
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is on track to submit ANX-530 505(b)(2) new drug application with data showing bioequivalence to GSK’S Navelbine in 2008.